BXP vs INMB · rev $895.7M vs rev $50.0K
Boston Properties Inc (BXP) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
BXP currently screens at market cap $12.12B. INMB currently screens at market cap $33.5M.
Not investment advice. Open the BXP and INMB stock pages for the full models.
Not investment advice.